Introduction

Cognition and Cancer

Volumn , Issue , 2008, Pages 3-5

  Meyers, Christina A ^a   Perry, James R ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885981899     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545900.002     Document Type: Chapter

References (6)

1. Dropcho EJ (2005). Update on paraneoplastic syndromes. Curr Opin Neurol 18(3): 331-336.
2. Lee BN, Dantzer R, Langley KE et al. (2004). A cytokine- based neuroimmunological mechanism of cancer-related symptoms. Neuroimmunomodulation 11: 279-292.
3. Meyers CA, Kudelka AP, Conrad CA, Gelke CK, Grove W, Pazdur R (1997). Neurotoxicity of CI-980, a novel mitotic inhibitor. Clin Cancer Res 3: 419-422.
4. Meyers CA, Albitar M, Estey E (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104: 788-793.
5. Scheibel RS, Valentine AD, O’Brien S, Meyers CA (2004). Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 16: 185 191.
6. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004). The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast cancer: results of a prospective, randomized, longitudinal trial. Cancer 100: 2292-2299.